Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer

M T Faber, A Jensen, K Frederiksen, Eva Glud, E Høgdall, C Høgdall, Jan Blaakær, S K Kjær

25 Citations (Scopus)

Abstract

Oral contraceptive use decreases the risk of ovarian cancer, but no previous studies have assessed the impact of cumulative intake of estrogen and progestin on ovarian cancer risk.
Original languageEnglish
JournalCancer causes & control
Pages (from-to)2197-2206
ISSN0957-5243
DOIs
Publication statusPublished - 29 Sept 2013

Fingerprint

Dive into the research topics of 'Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer'. Together they form a unique fingerprint.

Cite this